PFE News 30.39 07/24/2014 05:34:38 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 30.39 $PFE

What Will Puma Biotechnology Inc's $700 Million Man Do Next?
Brian Orelli, The Motley Fool - Motley Fool - Wed Jul 23, 6:21PM CDT
Alan Auerbach, CEO, president, and chairman of Puma Biotechnology , you just personally made over $700 million after your biotech suddenly soared 295% (more if you exercise all those warrants and options you have), what are you going to do now? ...

Most active New York Stock Exchange-traded stocks
AP - Wed Jul 23, 5:02PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Wed Jul 23, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense?
Alex Planes, The Motley Fool - Motley Fool - Wed Jul 23, 3:30PM CDT
The Dow Jones Industrial Average is a strange beast. With only 30 components, it can't possibly represent the scope of American stock markets as well as the broader S&P 500 . Yet not only does the Dow follow the S&P fairly closely in any...

Puma Biotechnology Stock Shoves It in Short Sellers' Faces
George Budwell, The Motley Fool - Motley Fool - Wed Jul 23, 3:01PM CDT
Biotech stocks are not for the faint of heart by any stretch of the imagination. Puma Biotechnology  has repeatedly shown the investing world why this is the case, and today's 200% plus movement upward should drive this point home.  PBYI ...

Why Puma Biotechnology Inc Stock More Than Tripled Today
Dan Carroll, The Motley Fool - Motley Fool - Wed Jul 23, 1:05PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Puma Biotechnology , a clinical-stage...

Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 12:41PM CDT
Shares of Puma Biotechnology, Inc. (PBYI) soared significantly after the company reported positive top-line results from the phase III trial on pipeline candidate, neratinib (PB272).

Midday Glance: Pharmaceuticals companies
AP - Wed Jul 23, 12:25PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:

Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 12:10PM CDT
Cubist's (CBST) second quarter earnings were short of the Zacks Consensus Estimate.

Early Glance: Pharmaceuticals companies
AP - Wed Jul 23, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Stock Market News for July 23, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 9:10AM CDT
Benchmarks settled in the green on Tuesday banking on encouraging housing data and upbeat corporate earnings results

Global Women's Health Market 2014-2018
M2 - Wed Jul 23, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4kxqgp/global_womens) has announced the addition of the "Global Women's Health Market 2014-2018" report to their offering. The Global Women's Health market will grow at a CAGR of 3.52 percent over the period 2013-2018. Women experience physiological and emotional issues during different phases of their life cycle due to hormonal changes. Women's health is especially referred to where reproductive health is involved. According to the Society for Women's Health Research in the US, issues specific to the human female anatomy are defined as women's health. The biological mechanisms influence the clinical course of diseases and disorders differently in women when compared to men. Some of the main women's health disorders include infertility, menopause, endometriosis and polycystic ovarian syndrome as well as urological disorders and cancers such as breast cancer, cervical cancer, endometrial cancer, and ovarian cancer. In addition, contraception plays an important role in women's health for many reasons, so this too is also categorized under women's health. To calculate the market size, the report considers revenue generated from the sales of various products used for the wellbeing of women, which are listed below based on their application segment: - Postmenopausal Osteoporosis (Drugs) - Hormonal Contraceptives (Drugs and Devices) - Menopause (Drugs) - Infertility (Drugs) - Endometriosis (Drugs) - Polycystic Ovary Syndrome (Drugs) The report, the Global Women's Health Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC regions; it also covers the Global Women's Health market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors - Actavis plc - Bayer AG - Eli Lilly and Co. - Merck & Co. - Pfizer Inc. According to the report, the growth of the Global Women's Health market is curtailed by some serious challenges. One of the main challenges is the patent expiry of major blockbuster drugs during the forecast period. Some of the patent expiries of top leading products include Bayer's Mirena and Yaz, Eli Lilly's Evista, and F. Hoffmann-La Roche's Boniva. For more information visit http://www.researchandmarkets.com/research/4k...bal_womens

Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx
PR Newswire - Wed Jul 23, 7:30AM CDT
Today, Analysts Review released its research reports regarding Pfizer Inc. (NYSE: PFE), Gentiva Health Services Inc. (NASDAQ: GTIV), bluebird bio, Inc. (NASDAQ: BLUE), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) and AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5013-100free.

Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023
M2 - Wed Jul 23, 4:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pjm9m/top_25) has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023" report to their offering. Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical industry, including the late-term pipeline of major companies. This report provides long-term company sales forecasts which are based on 2013 market conditions. For each company, the report provides: - Revenues - R&D Spending 2007-2013 - Geographic Breakout of Revenues - Performance of Specific Products - Performance by Drug Category - Late-Stage Pipeline - Projections of Revenues to 2023 In addition to specific company data and factors, there are a number of macroeconomic concerns affecting sales such as aging populations, incidence of disease, unmet medical needs, government activities, and more. The pharmaceutical market as a whole has witnessed a number of significant changes in recent years, providing both setbacks and new opportunities. The number of blockbuster pharmaceuticals reaching patent and exclusivity expiration status and vulnerable to generic competition has changed the landscape of the market for many manufacturers. The growing interest in biotechnology development has transitioned an industry once focused on chemical-based therapies to biologic therapies and produced exceptional changes in many areas of medical treatment over the last two decades. The companies included in the study are: - Pfizer, inc. - Novartis AG - Roche ltd. - Merck & Co., inc. - Sanofi - Glaxosmithkline PLC - Johnson & johnson - Astra Zeneca plc - Eli Lilly and Company - Abbvie, inc. - Teva Pharmaceutical Industries, Ltd. - Amgen, inc. - Bristol-myers Squibb Company - Takeda Pharmaceutical co., LTD - Bayer AG - Novo nordisk - Boehringer Ingelheim gmbh - Daiichi Sankyo - Astellas - Gilead Sciences - Otsuka Pharmaceutical - Merck KGAA - Actavis - Mylan - Baxter international For more information visit http://www.researchandmarkets.com/research/7pjm9m/top_25

Puma Biotechnology Inc's Overnight Triple is Just the Beginning
Brian Orelli, The Motley Fool - Motley Fool - Tue Jul 22, 7:03PM CDT
Look at that cat go. Puma Biotechnology more than tripled in afterhours after announcing that its phase 3 trial testing neratinib in breast cancer patients was successful. The trial enrolled patients with early breast tumors having a mutation...

Johnson & Johnson Announces $5B Share Buyback - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 5:25PM CDT
Johnson & Johnson (JNJ) announced its plan to buy back up to $5 billion of its common stock.

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 4:20PM CDT
Bayer (BAYRY) and Regeneron Pharmaceuticals (REGN) announced encouraging results from the phase III study on Eylea.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 14

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 52

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 0

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 0

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 46

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 138

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 370

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 0

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 123

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading

Top 5 Most Recently Viewed Articles

Cloudastructure's Innovative AI Prevents Crime with 98% Success

Updated Category News Views 134

Cloudastructure's Impressive AI-Driven Crime Prevention Cloudastructure, Inc. (Nasdaq: CSAI) has emerged as a frontrunner in AI surveillance and remote guarding, successfully achieving an impressive crime deterrence rate exceeding 98% within a short span. This significant accomplishment, highlighted during the early months of the year, underscores the platform's...

Continue Reading
Apollo Global Management's Growth Strategy and Investor Outlook

Updated Category News Views 576

Barclays kept its Overweight rating on Apollo Global Management (NYSE: APO) back in early 2024, setting a price target of $128. This came as traders braced for the highly anticipated 2024 Investor Day where Apollo was expected to reveal its medium and long-term strategic objectives. Key numbers like assets under management (AUM), fundraising capabilities, fee-related...

Continue Reading
Leadership Changes at BlackLine: A New Era Unfolds Ahead

Updated Category News Views 367

BlackLine's Leadership Transition: A Strategic Move BlackLine, Inc. (Nasdaq: BL), the leading platform driving digital finance transformation, has announced a pivotal leadership transition aimed at enhancing its operational framework and growth trajectory. Therese Tucker's Evolving Role In a move that reflects the company's commitment to its strategic objectives, Therese...

Continue Reading
Hargreave Hale AIM VCT PLC Updates on Share Transactions

Updated Category News Views 41

Hargreave Hale AIM VCT PLC Engages in Strategic Share Acquisition Hargreave Hale AIM VCT PLC is focused on boosting shareholder value by taking strategic actions in the market. Recently, the company made a noteworthy announcement regarding its shares. Details of the Share Acquisition On a significant date, Hargreave Hale AIM VCT PLC acquired 367,436 ordinary shares at a...

Continue Reading
Tanmiah's Commitment to Sustainability Shines at Halal Forum

Updated Category News Views 156

Tanmiah's Role at the Makkah Halal Forum Tanmiah Food Company (TADAWUL: 2281, "Tanmiah"), a frontrunner in halal protein, recently highlighted its dedication as a Platinum Sponsor at the Makkah Halal Forum. This event serves as a crucial platform for showcasing the best halal services and products, allowing Tanmiah to demonstrate its leadership and innovative edge in the...

Continue Reading